Corporate News Report – Psyched Wellness Ltd. (CSE)
Summary of the Q2 2026 Filing
Psyched Wellness Ltd. (Ticker: PWLD on the Canadian Securities Exchange) filed its Form 5 Quarterly Listing Statement for the period ended 31 May 2026 on 29 July 2026. The filing confirms the company’s compliance with Ontario securities law, provides unaudited interim financial statements, and discloses related‑party transactions and capital structure details. The directors and senior officers remain unchanged, with Michael Nederhoff continuing as Chief Executive Officer.
Key Financial Highlights
| Metric | Q2 2026 | Q2 2025 | % Change |
|---|---|---|---|
| Revenue | $1.27 M | $1.02 M | +24 % |
| EBITDA | $120 k | –$45 k | +271 % |
| Net Income | $95 k | –$30 k | +312 % |
| Cash & Equivalents | $3.8 M | $3.2 M | +19 % |
| Shares Outstanding | 14,200,000 | 13,900,000 | +2 % |
All figures are unaudited and presented in Canadian dollars.
The positive momentum in earnings is largely attributed to increased patient throughput and the expansion of the company’s digital therapeutic platform, which has begun to generate subscription revenue and partner‑based licensing fees.
Market Dynamics and Reimbursement Landscape
Psyched Wellness operates in the growing field of digital mental‑health therapeutics, a market projected to reach $12 B by 2030, with a compound annual growth rate (CAGR) of approximately 12 %. Key drivers include:
Shifting Reimbursement Models • Private insurers are increasingly covering digital therapeutics under value‑based payment frameworks. • Public payers in Ontario are testing pilot programs that reimburse for evidence‑based virtual care, potentially expanding coverage to Psyched Wellness’s core offerings.
Competitive Pressures • Traditional therapy providers are launching their own digital adjuncts, raising the bar for differentiation. • Technological incumbents such as BetterHelp and Talkspace command significant market share, making product innovation critical.
Regulatory Environment • The Canadian federal government’s “Digital Health Strategy” encourages the integration of technology into mental‑health care, creating an enabling regulatory climate. • Compliance with the Personal Health Information Protection Act (PHIPA) and the Digital Health Act remains a cost driver but is essential for market entry.
Operational Challenges
Scalability of Clinical Workforce Psyched Wellness has hired 12 new licensed clinicians over the quarter. Maintaining quality outcomes while expanding staff necessitates robust training protocols and ongoing outcome monitoring.
Data Security & Interoperability The platform must integrate with electronic health record (EHR) systems across multiple jurisdictions, raising both technical and privacy compliance costs.
Capital Allocation With cash reserves of $3.8 M, the company plans to allocate roughly 35 % of operating cash flow to research and development of next‑generation AI‑driven therapy modules.
Financial Viability of New Technologies
Using a discounted cash flow (DCF) framework and industry benchmarks (average net margin 18 % for digital therapeutics, discount rate 10 % reflecting sector risk), the projected net present value (NPV) of the platform’s first‑stage rollout is $8.5 M. This valuation aligns with recent peer valuations and supports an internal rate of return (IRR) of 22 %, indicating strong upside potential for shareholders.
Operationally, the cost per acquired patient has fallen from $480 in Q1 to $350 in Q2, reflecting improved marketing efficiency and patient retention. The company’s cost of goods sold (COGS) remains at $45 % of revenue, below the industry average of $55 %, suggesting favorable economies of scale.
Balancing Cost, Quality, and Access
Psyched Wellness’s approach emphasizes:
- Quality Outcomes – The platform reports an average reduction in PHQ‑9 scores of 4.2 points over 12 weeks, surpassing the benchmark of 3 points set by clinical guidelines.
- Cost Efficiency – By leveraging telehealth, the company reduces overheads associated with physical office spaces, translating into lower per‑patient costs.
- Patient Access – The service is available 24/7 across Canada, with an adaptive language interface that increases reach to non‑English‑speaking communities.
Governance and Compliance
The directors’ certification confirms adherence to all securities legislation and exchange rules. No material legal or regulatory changes were noted. The company remains fully authorized, with no restrictions on share transfer, and all securities issuances—including options and warrants—are disclosed in the filing.
Outlook
Psyched Wellness Ltd. demonstrates robust financial performance and a clear strategy for navigating an evolving reimbursement landscape. Continued investment in technology and workforce expansion, coupled with a disciplined cost structure, positions the company to capture a growing share of the digital mental‑health market while maintaining high patient‑centred outcomes.
